NEW YORK, April 30, 2012 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities law firm, is investigating the Senior Management and the Board of Directors of Gen-Probe Inc. (NASDAQ: GPRO) for possible breaches of fiduciary duty and other violations of state law. On April 30, 2012, Hologic, Inc. (NASDAQ: HOLX) announced that it has entered into a definitive merger agreement whereby Hologic will acquire all the outstanding shares of Gen-Probe for $82.75 per share in cash.
The investigation concerns, among other things, whether the consideration to be paid to Gen-Probe shareholders is unfair, inadequate, and substantially below the fair or inherent value of Gen-Probe, and whether the senior management of Gen-Probe are putting their own self-interests ahead of that of the Company's shareholders. Indeed, analysts project Gen-Probe's true going forward value is in excess of the merger consideration.
If you own common stock in Gen-Probe and wish to obtain additional information, please contact us at:
Tripp Levy PLLC
Toll free: 877-772-3975
SOURCE Tripp Levy PLLC
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here